Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 323

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Open access
Piccini, Jonathan P, Caso, Valeria, Connolly, Stuart J, Fox, Keith A A, Oldgren, Jonas, Jones, W Schuyler, Gorog, Diana A, Durdil, Václav, Viethen, Thomas, Neumann, Christoph, Mundl, Hardi, Patel, Manesh R, Auer, Johann, Hubauer, Martin, Pandzic, Sead, Preishuber, Eva, Primus-Grabscheit, Carina, Reitgruber, Dietmar, Schmalzer, Florian, Adlbrecht, Christopher, Schober, Andreas, Hajos, Johannes, Keil, Christoph, Schratter, Alexandra, Frick, Matthias, Benda, Magdalena Anna, Mächler, Maximilian, Mutschlechner, Beatrix, Saely, Christoph, Sprenger, Lukas, Lichtenauer, Michael, Eber, Miriam, Hoppe, Uta, Kolbitsch, Tobias, Jirak, Peter Michael, Mirna, Moritz, Schönbauer, Robert, Bergler-Klein, Jutta, Hengstenberg, Christian, Stojkovic, Stefan, Scherr, Daniel, Manninger-Wünscher, Martin, Rohrer, Ursula, Stühlinger, Markus, Schgoer, Wilfried, Schwarzl, Jana, Pürerfellner, Helmut, Derndorfer, Michael, Ebner, Christian, Eder, Veronika, Kollias, Georgios, Sturmberger, Thomas, Sieghartsleitner, Stefan, Vijgen, Johan, Koopman, Peter, Dujardin, Karl, Anné, Wim, De Ceuninck, Michel, Tavernier, Rene, Duytschaever, Mattias, Knecht, Sébastien, Missault, Luc, Vandekerckhove, Yves, Rossenbacker, Tom, Ector, Bavo, Charlier, Filip, Debruyne, Philippe, Dewilde, Willem, Janssens, Luc, Roosen, John, Vankelecom, Bart, Heidbuchel, Hein, Delesie, Michiel, Vervoort, Gert, Rombouts, Hans, Vanassche, Thomas, Engelen, Matthias, Verhamme, Peter, Willems, Rik, Constance, Christian, Pranno, Nicolas, Cox, Jafna, Bata, Iqbal, Macle, Laurent, Aguilar, Martin, Tourigny, Julia Cadrin, Dubuc, Marc, Dyrda, Katia, Guerra, Peter, Khairy, Paul, Mondésert, Blandine, Rivard, Léna, Roy, Denis, Tadros, Rafik, Talajic, Mario, Thibault, Bernard, Nault, Isabelle, Blier, Louis, Champagne, Jean, Molin, Franck, O'Hara, Gilles, Philippon, François, Plourde, Benoit, Sarrazin, Jean-François, Steinberg, Christian, Coufal, Zdenek, Balazsik, David, Mikulica, Michal, Zapeca, Jakub, Cermak, Ondrej, Drasnar, Tomas, Falc, Matej, Hornof, Josef, Racz, Blazej, Weissova, Danica, Linkova, Hana, Paskova, Eva, Petr, Robert, Sirakova, Andrea, Kettner, Jiri, Benak, Ales, Holek, Martin, Podpera, Ivo, Podperova, Monika, Vancura, Vlastimil, Jandik, Tomas, Smid, Jiri, Dedek, Vratislav, Banik, Jan, Durdil, Vaclav, Hnat, Tomas, Lellouche, Nicolas, Rouffiac, Ségolène, Taldir, Guillaume, Bridonneau, Valentin, Couffon, Philippe, Daudin, Magalie, Hamon, Cécile, Lacaze, Jonathan, Quentin, Anne, Thebault, Christophe, Boiffard, Emmanuel, Billon, Olivier, Miette, Fabien, Pouliquen, Hervé, Turlotte, Guillaume, Gorka, Hervé, Albert, Franck, Bayle, Sandrine, Bensaid, Reda, Dasoveanu, Madalina, Demichili, Thibaud, Dutoiu, Teodora, Khalil, Cliff, Loghin, Caterina, Range, Grégoire, Roussel, Laurent, Socié, Pierre, Thuaire, Christophe, Extramiana, Fabrice, Algalarrondo, Vincent, Boughanmi, Haten, El Mansour, Noreddine, Mohammad, Usman, Sellier, Romain, Elbaz, Meyer, Laperche, Clémence, Maury, Philippe, Kiss, Robert, Borsanyi, Tunde, Gingl, Zoltan, Polgar, Balaza, Benczur, Bela, Bodor, Alexandra, Hepp, Tamas, Malati, Eva, Nagy, Laszlo, Erdei, Norbert, Kapus, Jozsef, Kapus, Katalin, Toth, Brigitta, Matoltsy, Andras, Kiss, Tunde, Merkely, Bela, Herczeg, Szilvia, Kiss, Orsolya, Sallo, Zoltan, Toth, Kalman, Habon, Tamas, Rabai, Miklos, Totsimon, Kinga, Zilahi, Zsolt, Bencze, Gabriella, Santa, Janos, Aradi, Daniel, Kelemen, Barbara, Bolognese, Leonardo, Nesti, Martina, Notarstefano, Pasquale Giovanni, D'Orazio, Simona, Cosmi, Franco, Becattini, Cecilia, Agnelli, Giancarlo, Broccatelli, Belinda, Mosconi, Maria Giulia, Paciaroni, Maurizio, Urbini, Chiara, Parato, Vito Maurizio, Notaristefani, Camilla, Scarano, Michele, Ameri, Pietro, Ghigliotti, Giorgio, Guglielmi, Giulia, Lotti, Roberta, Merlo, Andrea Carlo, Muiesan, Maria Lorenza, Abondio, Andrea, Berasi, Caterina, Mattiuzzo, Elena, Mutti, Claudio, Salvetti, Massimo, Pignatelli, Pasquale, Menichelli, Danilo, Pastori, Daniele, Tamiya, Eiji, Matsumoto, Takahiro, Takabe, Tomosato, Yamamoto, Shoichi, Yamashita, Haruyo, Higashiue, Shinichi, Furuya, Onichi, Hiramatsu, Norihiko, Kasuga, Kensuke, Kojima, Saburo, Komooka, Masatoshi, Kuroyanagi, Satoshi, Matsuura, Makoto, Takemoto, Tetsushi, Yamamoto, Shuji, Saito, Katusmi, Abe, Takuro, Ishida, Issei, Iwanami, Yuji, Kataoka, Shohei, Moriyama, Tetsu, Murohashi, Akira, Sasaki, Akihito, Nakamura, Yuichiro, Ueno, Tetsuya, Shimane, Akira, Hamana, Tomoyo, Ichibori, Hirotoshi, Inoue, Tomohiro, Itoh, Mitsuaki, Iwane, Seigo, Kawai, Hiroya, Kokawa, Tatsuya, Masumoto, Akiko, Matsuo, Koki, Miyata, Taishi, Nakano, Shinsuke, Oishi, Shogo, Onishi, Tetsuari, Sawada, Takahiro, Saito, Takayuki, Shoda, Mitsuhiko, Takahashi, Nobuyuki, Takaya, Tomofumi, Taniguchi, Yasuyo, Tsukamoto, Shota, Tsukishiro, Yasue, Tsukiyama, Yoshiro, Tsunamoto, Hiroshi, Uzu, Kenzo, Yamamoto, Hiroyuki, Yamamoto, Tetsuya, Yokoi, Kiminobu, Yoshida, Chiaki, Watanabe, Nobuhiro, Betsuyaku, Tetsuo, Adachi, Kumiko, Awane, Kouichi, Goto, Daisuke, Sakakibara, Mamoru, Watanabe, Masashi, Ueno, Hideki, Hiroe, Yoshitaka, Matsuo, Koshi, Ayata, Kenji, Fukuda, Ko, Hata, Yoshiki, Hashimoto, Katsushi, Matsumi, Hiroaki, Nikaido, Akira, Okamoto, Shuichi, Sime, Iveta, Stirna, Valters, Reinholde, Ilze, Hansone, Silvija, Kozlovska, Anita, Romanova, Janina, Klincare, Dace, Pontaga, Natalja, Dirmans, Igors, Kalnins, Artis, Upite, Dana, Gersamija, Arcils, Teleznikovs, Arturs, Rozkova, Nadezda, Safro, Jelena, Anguera Camós, Ignasi, Domenico Dallaglio, Paolo, Salguero Bodes, Rafael, Arnbas, Fernando, Borrego, Luis, Marco, Alvaro, Jimenez, Javier Ramos, Gómez-Doblas, Juan José, Pérez Cabeza, Alejandro, Ferreira Gonzålez, Ignacio, Limeres Freire, Javier, Lopez Grau, Merce, Viñolas Prat, Xavier, Moreno Weidmann, Zoraida, Guerra Ramos, Jose Maria, Alonso Martin, Maria Concepcion, Campos Garcia, Bieito, Mogro Carranza, Javier Mauricio, Mendez Zurita, Francisco Javier, Rodriguez Font, Enrique, Gonzales Matos, Carlos Eduardo, García Hernando, Víctor, Lindholm, Carl-Johan, Thulin, Jörgen, Wallén, Håkan, Hagwall, Kristina, Eliasson, Ken, Lundvall, Martin, Olsson, Jens, Kjellman, Björn, Lind, Markus, Johansson, Lars, Svedberg, Niclas, Berglund, Stefan, Söderberg, Julia, Zedigh, Christer, Mooe, Thomas, Axelsson, Mattias, Binsell, Emil, Huber, Daniel, Müller, Christian, Danier, Isabelle, Kühne, Michael, Okamura, Bernhard, Schoepfer, Hadrien, Simmen, Cornelia, Reichlin, Tobias, Chollet, Laurève, Lam, Anna, Wittmer, Severin, Rickli, Hans, Gall, Christian, Hametner, Greta, Intorp, Stephanie, Luescher, Daniel, Haegeli, Laurent, Berg, Jan Christopher, Ebrahimi, Ramin, Auricchio, Angelo, Crljenica, Carmela, Moccetti, Tizziano, Monti, Cristina, Pasotti, Elena, Petrova, Iveta, Rossi, Mariagrazia, Mach, François, Namdar, Mehdi, de Groot, Joris, Proost, Virginnio, Neefs, Joline, Linz, Dominik, van Stipdonk, Twan, den Uijl, Dennis, Alings, Marco, Schaap, Jeroen, Segers, Dolf, Wouters, Noemi, Bartels, Louis, Tieleman, Robert, Pisters, Ron, de Vries, Tim, Selig, Jaap, Kuijper, Aaf, Bot, Pieter, Keijzers, Mitran, Verdel, Gerardus, Tukkie, Raymond, van den Bos, Ewout, Kauer, Floris, Oemrawsingh, Rohit, Stevenhagen, Jeroen, van Es, Jan, Lip, Gregory, Gupta, Dhiraj, Kotalczyk, Agnieszka, Gunstone, Anthony, Brixey, Richard David, Gorog, Diana, Dinarvand, Danial, Gue, Ying, Kanji, Rahim, Memtsas, Vassilios, Senior, Roxy, Bioh, Gabriel, Wong, Yuk-Ki, Child, Nick · 2022 · The Lancet

Abstract

Background Direct-acting oral anticoagulant use for stroke prevention in atrial fibrillation is limited by bleeding concerns. Asundexian, a novel, oral small molecule activated coagulation factor XIa (FXIa) inhibitor, might reduce thrombosis with minimal effect on haemostasis. We aimed to determine the optimal dose of asundexian and to compare the incidence of bleeding with that of apixaban in patients with atrial fibrillation. Methods In this randomised, double-blind, phase 2 dose-finding study, we compared asundexian 20 mg or 50 mg once daily with apixaban 5 mg twice daily in patients aged 45 years or older with atrial fibrillation, a CHA 2 DS 2 -VASc score of at least 2 if male or at least 3 if female, and increased bleeding risk. The study was conducted at 93 sites in 14 countries, including 12 European countries, Canada, and Japan. Participants were randomly assigned (1:1:1) to a treatment group using an interactive web response system, with randomisation stratified by whether patients were receiving a direct-acting oral anticoagulant before the study start. Masking was achieved using a double-dummy design, with participants receiving both the assigned treatment and a placebo that resembled the non-assigned treatment. The primary endpoint was the composite of major or clinically relevant non-major bleeding according to International Society on Thrombosis and Haemostasis criteria, assessed in all patients who took at least one dose of study medication. This trial is registered with ClinicalTrials.gov, NCT04218266, and EudraCT, 2019-002365-35. Findings Between Jan 30, 2020, and June 21, 2021, 862 patients were enrolled. 755 patients were randomly assigned to treatment. Two patients (assigned to asundexian 20 mg) never took any study medication, resulting in 753 patients being included in the analysis (249 received asundexian 20 mg, 254 received asundexian 50 g, and 250 received apixaban). The mean age of participants was 73·7 years (SD 8·3), 309 (41%) were women, 216 (29%) had chronic kidney disease, and mean CHA 2 DS 2 -VASc score was 3·9 (1·3). Asundexian 20 mg resulted in 81% inhibition of FXIa activity at trough concentrations and 90% inhibition at peak concentrations; asundexian 50 mg resulted in 92% inhibition at trough concentrations and 94% inhibition at peak concentrations. Ratios of incidence proportions for the primary endpoint were 0·50 (90% CI 0·14–1·68) for asundexian 20 mg (three events), 0·16 (0·01–0·99) for asundexian 50 mg (one event), and 0·33 (0·09–0·97) for pooled asundexian (four events) versus apixaban (six events). The rate of any adverse event occurring was similar in the three treatment groups: 118 (47%) with asundexian 20 mg, 120 (47%) with asundexian 50 mg, and 122 (49%) with apixaban. Interpretation The FXIa inhibitor asundexian at doses of 20 mg and 50 mg once daily resulted in lower rates of bleeding compared with standard dosing of apixaban, with near-complete in-vivo FXIa inhibition, in patients with atrial fibrillation. Funding Bayer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(22)00456-1

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 323

Metadata

Authors
Piccini, J. P., Caso, V., Connolly, S. J., Fox, K. A. A., Oldgren, J., Jones, W. S., Gorog, D. A., Durdil, V., Viethen, T., Neumann, C., Mundl, H., Patel, M. R., Auer, J., Hubauer, M., Pandzic, S., Preishuber, E., Primus-Grabscheit, C., Reitgruber, D., Schmalzer, F., Adlbrecht, C., Schober, A., Hajos, J., Keil, C., Schratter, A., Frick, M., Benda, M. A., Mächler, M., Mutschlechner, B., Saely, C., Sprenger, L., Lichtenauer, M., Eber, M., Hoppe, U., Kolbitsch, T., Jirak, P. M., Mirna, M., Schönbauer, R., Bergler-Klein, J., Hengstenberg, C., Stojkovic, S., Scherr, D., Manninger-Wünscher, M., Rohrer, U., Stühlinger, M., Schgoer, W., Schwarzl, J., Pürerfellner, H., Derndorfer, M., Ebner, C., Eder, V., Kollias, G., Sturmberger, T., Sieghartsleitner, S., Vijgen, J., Koopman, P., Dujardin, K., Anné, W., De Ceuninck, M., Tavernier, R., Duytschaever, M., Knecht, S., Missault, L., Vandekerckhove, Y., Rossenbacker, T., Ector, B., Charlier, F., Debruyne, P., Dewilde, W., Janssens, L., Roosen, J., Vankelecom, B., Heidbuchel, H., Delesie, M., Vervoort, G., Rombouts, H., Vanassche, T., Engelen, M., Verhamme, P., Willems, R., Constance, C., Pranno, N., Cox, J., Bata, I., Macle, L., Aguilar, M., Tourigny, J. C., Dubuc, M., Dyrda, K., Guerra, P., Khairy, P., Mondésert, B., Rivard, L., Roy, D., Tadros, R., Talajic, M., Thibault, B., Nault, I., Blier, L., Champagne, J., Molin, F., O'Hara, G., Philippon, F., Plourde, B., Sarrazin, J.-F., Steinberg, C., Coufal, Z., Balazsik, D., Mikulica, M., Zapeca, J., Cermak, O., Drasnar, T., Falc, M., Hornof, J., Racz, B., Weissova, D., Linkova, H., Paskova, E., Petr, R., Sirakova, A., Kettner, J., Benak, A., Holek, M., Podpera, I., Podperova, M., Vancura, V., Jandik, T., Smid, J., Dedek, V., Banik, J., Durdil, V., Hnat, T., Lellouche, N., Rouffiac, S., Taldir, G., Bridonneau, V., Couffon, P., Daudin, M., Hamon, C., Lacaze, J., Quentin, A., Thebault, C., Boiffard, E., Billon, O., Miette, F., Pouliquen, H., Turlotte, G., Gorka, H., Albert, F., Bayle, S., Bensaid, R., Dasoveanu, M., Demichili, T., Dutoiu, T., Khalil, C., Loghin, C., Range, G., Roussel, L., Socié, P., Thuaire, C., Extramiana, F., Algalarrondo, V., Boughanmi, H., El Mansour, N., Mohammad, U., Sellier, R., Elbaz, M., Laperche, C., Maury, P., Kiss, R., Borsanyi, T., Gingl, Z., Polgar, B., Benczur, B., Bodor, A., Hepp, T., Malati, E., Nagy, L., Erdei, N., Kapus, J., Kapus, K., Toth, B., Matoltsy, A., Kiss, T., Merkely, B., Herczeg, S., Kiss, O., Sallo, Z., Toth, K., Habon, T., Rabai, M., Totsimon, K., Zilahi, Z., Bencze, G., Santa, J., Aradi, D., Kelemen, B., Bolognese, L., Nesti, M., Notarstefano, P. G., D'Orazio, S., Cosmi, F., Becattini, C., Agnelli, G., Broccatelli, B., Mosconi, M. G., Paciaroni, M., Urbini, C., Parato, V. M., Notaristefani, C., Scarano, M., Ameri, P., Ghigliotti, G., Guglielmi, G., Lotti, R., Merlo, A. C., Muiesan, M. L., Abondio, A., Berasi, C., Mattiuzzo, E., Mutti, C., Salvetti, M., Pignatelli, P., Menichelli, D., Pastori, D., Tamiya, E., Matsumoto, T., Takabe, T., Yamamoto, S., Yamashita, H., Higashiue, S., Furuya, O., Hiramatsu, N., Kasuga, K., Kojima, S., Komooka, M., Kuroyanagi, S., Matsuura, M., Takemoto, T., Yamamoto, S., Saito, K., Abe, T., Ishida, I., Iwanami, Y., Kataoka, S., Moriyama, T., Murohashi, A., Sasaki, A., Nakamura, Y., Ueno, T., Shimane, A., Hamana, T., Ichibori, H., Inoue, T., Itoh, M., Iwane, S., Kawai, H., Kokawa, T., Masumoto, A., Matsuo, K., Miyata, T., Nakano, S., Oishi, S., Onishi, T., Sawada, T., Saito, T., Shoda, M., Takahashi, N., Takaya, T., Taniguchi, Y., Tsukamoto, S., Tsukishiro, Y., Tsukiyama, Y., Tsunamoto, H., Uzu, K., Yamamoto, H., Yamamoto, T., Yokoi, K., Yoshida, C., Watanabe, N., Betsuyaku, T., Adachi, K., Awane, K., Goto, D., Sakakibara, M., Watanabe, M., Ueno, H., Hiroe, Y., Matsuo, K., Ayata, K., Fukuda, K., Hata, Y., Hashimoto, K., Matsumi, H., Nikaido, A., Okamoto, S., Sime, I., Stirna, V., Reinholde, I., Hansone, S., Kozlovska, A., Romanova, J., Klincare, D., Pontaga, N., Dirmans, I., Kalnins, A., Upite, D., Gersamija, A., Teleznikovs, A., Rozkova, N., Safro, J., Anguera Camós, I., Domenico Dallaglio, P., Salguero Bodes, R., Arnbas, F., Borrego, L., Marco, A., Jimenez, J. R., Gómez-Doblas, J. J., Pérez Cabeza, A., Ferreira Gonzålez, I., Limeres Freire, J., Lopez Grau, M., Viñolas Prat, X., Moreno Weidmann, Z., Guerra Ramos, J. M., Alonso Martin, M. C., Campos Garcia, B., Mogro Carranza, J. M., Mendez Zurita, F. J., Rodriguez Font, E., Gonzales Matos, C. E., García Hernando, V., Lindholm, C.-J., Thulin, J., Wallén, H., Hagwall, K., Eliasson, K., Lundvall, M., Olsson, J., Kjellman, B., Lind, M., Johansson, L., Svedberg, N., Berglund, S., Söderberg, J., Zedigh, C., Mooe, T., Axelsson, M., Binsell, E., Huber, D., Müller, C., Danier, I., Kühne, M., Okamura, B., Schoepfer, H., Simmen, C., Reichlin, T., Chollet, L., Lam, A., Wittmer, S., Rickli, H., Gall, C., Hametner, G., Intorp, S., Luescher, D., Haegeli, L., Berg, J. C., Ebrahimi, R., Auricchio, A., Crljenica, C., Moccetti, T., Monti, C., Pasotti, E., Petrova, I., Rossi, M., Mach, F., Namdar, M., de Groot, J., Proost, V., Neefs, J., Linz, D., van Stipdonk, T., den Uijl, D., Alings, M., Schaap, J., Segers, D., Wouters, N., Bartels, L., Tieleman, R., Pisters, R., de Vries, T., Selig, J., Kuijper, A., Bot, P., Keijzers, M., Verdel, G., Tukkie, R., van den Bos, E., Kauer, F., Oemrawsingh, R., Stevenhagen, J., van Es, J., Lip, G., Gupta, D., Kotalczyk, A., Gunstone, A., Brixey, R. D., Gorog, D., Dinarvand, D., Gue, Y., Kanji, R., Memtsas, V., Senior, R., Bioh, G., Wong, Y.-K., & Child, N.
Venue
The Lancet
Publisher
Elsevier BV
Published
2022-04
Volume
399
Issue
10333
Pages
1383-1390
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W4223439574
Cited by
323
References
18
FWCI
44.56
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study. https://app.cochat.ai/papers/10.1016/s0140-6736(22)00456-1
The paper
Piccini, J. P., Caso, V., Connolly, S. J., Fox, K. A. A., Oldgren, J., Jones, W. S., Gorog, D. A., Durdil, V., Viethen, T., Neumann, C., Mundl, H., Patel, M. R., Auer, J., Hubauer, M., Pandzic, S., Preishuber, E., Primus-Grabscheit, C., Reitgruber, D., Schmalzer, F., . . . Child, N. (2022). Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study. The Lancet. https://doi.org/10.1016/s0140-6736(22)00456-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.